ArticleJournal of translational medicine2025

A phase Ia study of a novel anti-HER2 antibody-drug conjugate GQ1001 in patients with previously treated HER2 positive advanced solid tumors.

Chenfei Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.